Document Analysis NLP IA
FREQ, RAKE or TFIDF
Summary (IA Generated)
The Food and Drug Administration is preparing to expand authorization for the use of the Pfizer–BioNTech coronavirus vaccine to children ages 12 to 15 next week, granting access to millions of young Americans, according to multiple reports.
The New York Times, citing officials familiar with the plans, first reported Monday that the FDA is set to grant the drugmakers expanded emergency use authorization, a key step in raising the country’s immunity levels that would in turn reduce the numbers of hospitalizations and deaths.
The companies have also begun a clinical trial into the use of the vaccine in children ages 5 to 11.
More than 147 million people have received at least one dose of a coronavirus vaccine in the United States, and about 131 million jabs have been of the Pfizer-BioNTech shot, according to the CDC.
A HuffPost Guide To Coronavirus.